logo-loader
RNS
TT Electronics PLC

TT Electronics PLC - Ground-breaking COVID-19 screening device launched

RNS Number : 5475Y
TT Electronics PLC
09 September 2020
 

 

 

9 September 2020

 

TT Electronics plc

 

Ground-breaking COVID-19 screening device launched

 

Further to its initial announcement on 1 September 2020, TT Electronics plc ("TT") notes the announcement made today by iAbra in relation to the successful trial and launch of Virolens®, its COVID-19 screening device.  TT has been working with British start up iAbra, and its partners including Intel, to design, develop and test the prototype Virolens® system and to specify and design the manufacturing processes for its commercial launch.  

Description of the Virolens® screening device

The Virolens® COVID-19 screening device uses microscopic holographic imaging and artificial intelligence (AI) software technology to detect the presence of the COVID-19 virus from a non-intrusive saliva swab test within 20 seconds. The device does not need to be administered by healthcare professionals and is expected to be used in airports, offices, sports venues and many other locations where people need to be in close proximity to each other.

 

Virolens® will enable safer access for everyone to places of work, transport and events by providing a quick, easy, repeatable and low-cost COVID-19 test, allowing hundreds of tests per machine each day. It will allow people to get on with their everyday lives in the knowledge they are in a safe environment. In partnership with Heathrow Airport, the system has successfully completed a first round of testing and  is about to embark on clinical trials which would be necessary for it to be certified for medical use.

 

Initial commercial launch and potential

TT has been appointed exclusive manufacturing partner for the commercial launch of Virolens®, which incorporates a number of TT proprietary products. TT has received initial orders for devices and testing cartridges which will be delivered to potential launch customers  in September and October 2020 with a value of circa £2 million. Whilst the range of potential outcomes remains very broad, as an early indication of the potential value of Virolens to TT, iAbra has indicated its intent to purchase further devices and cartridges with associated revenue to TT of circa £280 million. This is based on expressions of interest from more than a dozen end customers whose assessment of Virolens® are at varying stages. This additional revenue is dependent on iAbra's end customers converting their expressions of interest into firm orders and subject to Virolens® meeting regulatory authority requirements.  Delivery of these further orders could commence in Q4 2020 and would continue into 2021.

Selection of TT as a Virolens® partner

iAbra is a technology company founded in 2010 and headquartered in Bedfordshire, UK.  It has been developing neural network image analysis software for 10 years with applications in autonomous driving already in production. Virolens® is based on the new application of this existing technology and has been developed in partnership with TT and powered by Intel. TT was selected as the design and manufacturing partner because of its ability to develop an idea from concept into a fully functioning machine, which can be produced in volume. TT's engineering expertise and sub-system product capability, coupled with its global manufacturing footprint, have been a significant contributor to the rapid development of iAbra's concept design to the point of announcement today.

Manufacturing in TT's Hartlepool, UK facility

TT will manufacture Virolens® at its Hartlepool, UK facility, part of its Power and Connectivity division, for this launch phase.  TT will invest up to £5 million to support this phase of the programme and the launch of Virolens® globally.  Additional device production and cartridge assembly may also take place at other TT locations, as required.

 

Commenting Richard Tyson, Chief Executive Officer said:

 

"I am proud that we are a core part of the team behind the ground-breaking Virolens® programme. This project is evidence of the success of our strategy to position the business in higher technology, structural growth markets, using our engineering expertise to develop products in collaboration with our customers.

 

Virolens® has the potential to be a major step forward in dealing with the impact of the COVID-19 pandemic, by allowing safer access to places of work, transport and events.  TT's leading-edge products and flexible manufacturing capabilities provide significant support to critical aspects of the Virolens® device.  

 

This programme also has the potential to deliver a step change in TT's organic growth and to accelerate the achievement of our target operating margins. Assuming the launch is successful,  there are significant opportunities around the world for further orders."

 

 

For further information please contact:

 

 

TT Electronics plc            

Tel: +44 (0)1932 827 779

Richard Tyson, Chief Executive Officer

Mark Hoad, Chief Financial Officer

Julian Wais, Head of Investor Relations and Communications

 

 

MHP

Tel: +44 (0)7860 821 978

Tim Rowntree / Rachel Mann / Isabella Grace

 

 

About TT Electronics

TT Electronics is a global provider of engineered electronics for performance-critical applications.

The company operates in industries where there are structural growth drivers, working with market-leading customers primarily in aerospace and defence, medical and industrial sectors.  Products designed and manufactured include sensors, power management devices and connectivity solutions. TT has design and manufacturing facilities including in the UK, US, Mexico, Sweden and Asia.

The company has three divisions.  The Power and Connectivity division designs and manufactures power application products and connectivity devices which enable the capture and wireless transfer of data.  We collaborate with our customers to develop innovative solutions to optimise their electronic systems.  The Global Manufacturing Solutions division provides manufacturing services and engineering solutions for our product divisions and to customers that often require a lower volume and higher mix of products.  We manufacture complex integrated product assemblies for our customers and provide engineering services including designing testing solutions and value-engineering.  The Sensors and Specialist Components division works with customers to develop standard and customised solutions including sensors and power management devices.  Our solutions improve the precision, speed and reliability of critical aspects of our customers' applications. 

Cautionary statement

This announcement contains forward-looking statements. These have been made by the directors in good faith based on the information available to them up to the time of their approval of this update. The directors can give no assurance that these expectations will prove to have been correct. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward-looking information, actual results may differ materially from those expressed or implied by these forward-looking statements. The directors undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUCPBUPUPGB
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

6 min read